Nicholas Sauder1, Veronique Vestergaard2, Saira Siddiqui3, Vincent P Galea1, Charles R Bragdon4, Henrik Malchau5, Karim A Elsharkawy3, James I Huddleston6, Roger H Emerson3. 1. Harris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, MA. 2. Harris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, MA; Department of Orthopaedic Surgery, Slagelse Hospital, Slagelse, Region Zealand, Denmark; Department of Orthopedic Surgery, Copenhagen University Hospital, Hvidovre, Capital Region of Denmark, Denmark. 3. Texas Center for Joint Replacement, Plano, TX. 4. Harris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, MA; Department of Orthopaedic Surgery, Harvard Medical School, Boston, MA. 5. Harris Orthopaedic Laboratory, Massachusetts General Hospital, Boston, MA; Department of Orthopedics, Sahlgrenska University Hospital, Mölndal, Västergötland, Sweden. 6. Department of Orthopaedic Surgery, Stanford University Medical Center, Redwood City, CA.
Abstract
BACKGROUND: The direct anterior approach to total hip arthroplasty (THA) may result in superior early postoperative patient-reported outcome measures (PROMs). This study compared PROMs between THA patients treated with the direct anterior or posterolateral approach between 1.5 months and 5 years, using literature-derived patient acceptable symptom state (PASS) and minimal clinically important improvement (MCII) thresholds. METHODS: A propensity score match of 93 direct anterior patients to 93 posterolateral patients from a multicenter US collaboration (6 centers, 398 patients) was performed. The Harris Hip Score (HHS), the Short-Form 36, and a Numerical Rating Scale for Pain were collected preoperatively, postoperatively (mean days: 47), and at 1, 3, and 5 years. The proportion of patients reaching the HHS PASS, Pain MCII, and Function MCII in the direct anterior and posterolateral groups was compared using binary logistic regressions, controlling for age, gender, body mass index, and Charnley score. RESULTS: Direct anterior patients were less likely to reach the HHS PASS at the postoperative visit (P = .015; odds ratio = 0.454), but not at later visits (P > .082). Direct anterior patients had no difference from posterolateral patients in their tendency to reach the Pain MCII postoperatively or at 1 year (P > .090). The direct anterior patients were less likely to reach the Function MCII at the postoperative visit (P = .011; odds ratio = 0.422), but not at 1 year (P = .958). CONCLUSION: No evidence was found of superior early postoperative PROM scores in THA patients treated with the direct anterior approach. No PROM differences were found at or beyond 1 year, indicating that patients reach similar final symptom states, regardless of surgical approach.
BACKGROUND: The direct anterior approach to total hip arthroplasty (THA) may result in superior early postoperative patient-reported outcome measures (PROMs). This study compared PROMs between THApatients treated with the direct anterior or posterolateral approach between 1.5 months and 5 years, using literature-derived patient acceptable symptom state (PASS) and minimal clinically important improvement (MCII) thresholds. METHODS: A propensity score match of 93 direct anterior patients to 93 posterolateral patients from a multicenter US collaboration (6 centers, 398 patients) was performed. The Harris Hip Score (HHS), the Short-Form 36, and a Numerical Rating Scale for Pain were collected preoperatively, postoperatively (mean days: 47), and at 1, 3, and 5 years. The proportion of patients reaching the HHS PASS, Pain MCII, and Function MCII in the direct anterior and posterolateral groups was compared using binary logistic regressions, controlling for age, gender, body mass index, and Charnley score. RESULTS: Direct anterior patients were less likely to reach the HHS PASS at the postoperative visit (P = .015; odds ratio = 0.454), but not at later visits (P > .082). Direct anterior patients had no difference from posterolateral patients in their tendency to reach the Pain MCII postoperatively or at 1 year (P > .090). The direct anterior patients were less likely to reach the Function MCII at the postoperative visit (P = .011; odds ratio = 0.422), but not at 1 year (P = .958). CONCLUSION: No evidence was found of superior early postoperative PROM scores in THApatients treated with the direct anterior approach. No PROM differences were found at or beyond 1 year, indicating that patients reach similar final symptom states, regardless of surgical approach.
Authors: Kelvin Y Kim; James E Feng; Afshin A Anoushiravani; Edward Dranoff; Roy I Davidovitch; Ran Schwarzkopf Journal: J Arthroplasty Date: 2018-03-17 Impact factor: 4.757
Authors: R Meneghini; Wilford Gibson; David Halsey; Douglas Padgett; Keith Berend; Craig J Della Valle Journal: J Arthroplasty Date: 2018-12 Impact factor: 4.757
Authors: Mary Ziemba-Davis; Mark Nielson; Kent Kraus; Nathan Duncan; Nimra Nayyar; R Michael Meneghini Journal: J Arthroplasty Date: 2019-03-12 Impact factor: 4.757
Authors: P Maxwell Courtney; Mark I Froimson; R Michael Meneghini; Gwo-Chin Lee; Craig J Della Valle Journal: J Arthroplasty Date: 2018-01-16 Impact factor: 4.757
Authors: Nicholas N DePhillipo; Christopher M Larson; Owen R O'Neill; Robert F LaPrade Journal: J Bone Joint Surg Am Date: 2020-06-03 Impact factor: 6.558
Authors: M Lane Moore; Joseph C Brinkman; Jordan R Pollock; David G Deckey; Justin L Makovicka; Joshua S Bingham Journal: Arthroplast Today Date: 2022-09-21
Authors: John Realyvasquez; Vivek Singh; Akash K Shah; Dionisio Ortiz; Joseph X Robin; Andrew Brash; Mark Kurapatti; Roy I Davidovitch; Ran Schwarzkopf Journal: Arthroplasty Date: 2022-01-02